tirzepatide pregnancy contraindication and Pregnancy: Safety, Risks, and What Doctors Say Semaglutide & Tirzepatide Weight Loss

These data suggest hair loss on tirzepatide and hair loss on semaglutide can occur for some patients during active weight reduction, but it is not universal and was generally mild in studies

Important additional warnings include: discontinuation if pregnancy is recognized

It usually improves significantly as the body adjusts

Vitamin E l cht chng oxy ha gip bo v da khi cc gc t do

Most common AEs: nausea, diarrhea, vomiting, constipation mostly mild-to-moderate Onset: events concentrated during the 20-week titration period Discontinuation due to AEs: 4.3% (5 mg), 7.1% (10 mg), 6.2% (15 mg) vs 2.6% placebo Serious AEs: similar incidence across tirzepatide and placebo groups New signals: none identified beyond the known GLP-1 / GIP class profile Clinical significance Why SURMOUNT-1 reset the field Three observations stood out when SURMOUNT-1 was published in NEJM in 2022, and they still shape how Dr

Stalled results on a GLP-1 medication may point to an untreated hormone gap, not medication failure